Abstract |
Borderline personality disorder does not have a first choice pharmacological treatment. We studied 20 borderline inpatients in a double-blind parallel placebo-controlled trial with carbamazepine for a mean of 30.9 days. No significant positive effects of the drug were found.
|
Authors | J M de la Fuente, F Lotstra |
Journal | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
(Eur Neuropsychopharmacol)
Vol. 4
Issue 4
Pg. 479-86
(Dec 1994)
ISSN: 0924-977X [Print] Netherlands |
PMID | 7894258
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
|
Topics |
- Adult
- Behavior
- Borderline Personality Disorder
(drug therapy, psychology)
- Carbamazepine
(therapeutic use)
- Cross-Over Studies
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Psychiatric Status Rating Scales
|